Cristina is giving the keynote at the BioBeat21 Summit on 9th November, where an international community of scientists, innovators, entrepreneurs and investors will join together to discuss what the future holds for digital innovation in clinical trials.
BioBeat Founder Miranda Weston-Smith and Catherine Priestley, Head of BioPharmaceuticals R&D Communications, AstraZeneca, spoke to Cristina about the opportunities for improving patient-centered care that lie at the convergence of healthcare and digital technologies.